Investigation of the pharmacokinetics and metabolic fate of Fasiglifam (TAK-875) in male and female rats following oral and intravenous administration

This publication has 21 references indexed in Scilit:

• Efficacy and safety of fasiglifam ( TAK ‐875), a G protein‐coupled receptor 40 agonist, in J apanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double‐blind, placebo‐controlled, phase III trial
  Diabetes, Obesity and Metabolism, 2015
• Fasiglifam as a new potential treatment option for patients with type 2 diabetes
  Expert Opinion on Pharmacotherapy, 2013
• Metabolism of Xenobiotic Carboxylic Acids: Focus on Coenzyme A Conjugation, Reactivity, and Interference with Lipid Metabolism
  Chemical Research in Toxicology, 2013
• In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs
  Chemical Research in Toxicology, 2012
• Diclofenac metabolism in the mouse: Novelin vivometabolites identified by high performance liquid chromatography coupled to linear ion trap mass spectrometry
  Xenobiotica, 2011
• Predictability of Idiosyncratic Drug Toxicity Risk for Carboxylic Acid-Containing Drugs Based on the Chemical Stability of Acyl Glucuronide
  Drug Metabolism and Disposition, 2010
• PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
  Computer Methods and Programs in Biomedicine, 2010
• Integrated HPLC-MS and¹H-NMR spectroscopic studies on acyl migration reaction kinetics of model drug ester glucuronides
  Xenobiotica, 2009
• Generic dealkylation: a tool for increasing the hit‐rate of metabolite rationalization, and automatic customization of mass defect filters
  Rapid Communications in Mass Spectrometry, 2009
• A Novel Bioactivation Pathway for 2-[2-(2,6-Dichlorophenyl)aminophenyl]ethanoic Acid (Diclofenac) Initiated by Cytochrome P450-Mediated Oxidative Decarboxylation
  Drug Metabolism and Disposition, 2008